Error: Could not add to watchlist. X

Tyme Technologies Inc

+ Watchlist
GGET:US
Ticker Change
GGET:US has changed to a new ticker symbol
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Tyme Technologies, Inc. is a clinical-stage pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for oncology indications. The Company's treatments utilizes oxidative stress and the body's own immune defenses to treat cancer.
ADDRESS
48 Wall Street
Suite 1100
New York, NY 10005
United States
PHONE
1-646-205-1603
  • Steven Hoffman
    Chief Executive Officer
  • Peter E De Svastich
    President/Treasurer/Secretary
  • Michael Demurjian
    Chief Operating Officer
  • Robert Dickey
    VP:Finance/CFO
  • Ram Selvaraju
    Investor Relations
Show More